Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center

INTRODUCTION: Rituximab (RTX) is a therapeutic option in pediatric difficult-to-treat idiopathic nephrotic syndrome (NS). We aimed to assess the efficacy and safety of RTX use in these patients. METHOD: A retrospective study of all patients with idiopathic NS treated with RTX was conducted in a pedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Rita, Mosca, Sara, Bastos-Gomes, Mariana, Correia-Costa, Liane, Rocha, Liliana, Teixeira, Ana, Costa, Teresa, Sameiro-Faria, Maria, Matos, Paula, Mota, Conceição
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697169/
https://www.ncbi.nlm.nih.gov/pubmed/36259942
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0056en

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697169/
https://www.ncbi.nlm.nih.gov/pubmed/36259942
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0056en

Ejemplares similares